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states. Two non-PDL states were used as controls for underlying
market dynamics. Demographics of physicians’ neighborhoods
(poverty and ethnicity) were used to examine the variation in
prescribing based on the characteristics of physicians’ areas of
practice. RESULTS: The post-policy decline in the use of
restricted prescriptions varied considerably, from Florida (−97%)
to Texas (−65%). There was a statistically signiﬁcant positive
association between the magnitude of decline and the share of
impoverished households and the share of the minority popula-
tion in Alabama, Florida and Texas. CONCLUSION: The analy-
sis indicates that there is considerable variation in the impact of
a PDL by state, and in certain states by the degree of poverty or
diversity in the neighborhood. This could imply due to the PDL,
in poorer and more ethnically diverse neighborhoods, fewer
patients receive the restricted medication by prior authorization,
and more patients experience a disruption in their medication
regimen and any resultant unintended consequences. This is an
area worthy of exploration, as the dual eligibles transition into
Medicare part D and may experience changes in formulary.
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OBJECTIVES: To assess racial disparities in initial diagnosis and
follow-up treatment of hypertension. METHODS: This study
identiﬁed newly diagnosed hypertension patients using Medical
Expenditure Panel Survey (MEPS) 1996–2003. Hypertension
was based on self-reported medical conditions with clinical clas-
siﬁcation of “essential hypertension” (CCCODEX = “098”) 
or “hypertension with complications” (CCCODEX = “099”).
Patients were considered newly diagnosed if they reported their
condition to have started during the interview period and had
medical event records on the same dates for hypertension. In
order to assess racial disparities in follow-up treatment, eligible
patients were also required to remain in the survey for at least
6 months immediately after their initial diagnoses. Multivariate
logistic regression method was applied to exam the likelihood of
being initially diagnosed during ofﬁce-based visits and the prob-
ability of having follow-up ofﬁce-based visits using survey pro-
cedures in SAS 9.1 to take into account of complex survey design
and possible confounding factors. RESULTS: The ﬁnal data set
had 572 patients, representing 5.9 million civilian non-institu-
tionalized hypertension patients during years 1996–2003. More
Hispanics (14%, 95% CI = 6–21%) and non-Hispanic Blacks
(15%, 95% CI = 6–24%) were initially diagnosed during non-
ofﬁce-based visits (e.g. ER visits), compared with Whites (8%,
95% CI: 6–11%). After adjusting for confounding factors (age,
gender, family income, education, concurrent medical conditions
and health insurance status), both Hispanics (OR = 0.67, 95%
CI = 0.35–1.27) and non-Hispanic Blacks (OR = 0.56, 95% CI
= 0.25–1.21) had lower odds of being initially diagnosed during
ofﬁce-based visits compared to Whites, although neither esti-
mates were statistically signiﬁcant. Hispanics and Blacks were
also estimated to have lower odds of receiving follow-up ofﬁce-
based visits related to hypertension (Hispanic: OR = 0.83, 95%
CI = 0.45–1.52; Black: OR = 0.59, 95% CI = 0.37–0.94). CON-
CLUSION: Statistically signiﬁcant racial disparities in the likeli-
hood of initial diagnosis of hypertension during ofﬁce-based
visits were not found, although non-Hispanic Blacks were sig-
niﬁcantly less likely to receive follow-up ofﬁce-based visits for
hypertension.
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OBJECTIVES: This analysis examines the effect of mental health
on the health care cost of those suffering from diseases of the
heart. METHODS: We examined Tennessee Medicare reim-
bursement ﬁles for 2002 (inpatient, outpatient, and physicians)
for elderly with diseases of the heart (ICD-9 diagnosis; n =
294,322). The sample included blacks (9.8%), females (57.8%),
and those with a mental health diagnosis (15.16%; n = 44,605).
Analyses of variance and regression (controlling for age, sex, and
race) compared the cost differences between those with and
without mental health diagnosis. RESULTS: The total health
care cost per patient for those with a mental disorder was sig-
niﬁcantly higher than for those without a mental disorder
($35,865 vs. 18,863, p < 0.01; a difference of $17,002 per
patient). After controlling for age, race, and sex, the average cost
per patient reduced by $4,865, that is, from $35,865 to $31,000.
Approximately 8% of the total health cost was for treatment of
mental disorders. Further, among those having both diseases of
the heart and mental disorder, the total health cost was signiﬁ-
cantly higher for males than females ($40,762 vs. $33,865), and
for blacks than whites ($45,855 vs. $34,621). CONCLUSION:
Health care cost is signiﬁcantly higher among heart disease
patients with a mental disorder. A signiﬁcant saving of $4,865
per patient leading to cost saving of 21.7 million could be
attained ($4,865 × 44,605 patients = $21.7 million) through a
special management team that provided treatment parity across
the board.
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OBJECTIVES: To compare the burden of illness among patients
at high and low risk of developing a major cardiovascular event.
METHODS: The retrospective claims analysis included adult
commercial health plan members identiﬁed with a primary diag-
nosis for cardiovascular disease (CVD) such as angina pectoris,
myocardial infarction, hypertension, ischemic heart disease, and
stroke from January 1, 2001–December 31, 2002. The Baseline
period was deﬁned as the 12 month period following the ﬁrst
claim meeting the identiﬁcation criteria within that timeframe.
The Follow-up period was deﬁned as the 24 months following
the Baseline period. Members were categorized into three risk
groups: low risk (LR), high risk (HR), and high risk aged 55 and
over (HR55). Demographic and clinical characteristics, utiliza-
tion, and costs were analyzed for the risk groups. Patients who
died were removed from this analysis and examined separately
due to signiﬁcant differences from the overall study population.
RESULTS: Most patients fell into the low risk group (8% in
HR55, 7% in HR, 85% in LR) based on the study criteria. A
signiﬁcantly greater proportion of patients in the HR55 group
were hospitalized during follow-up (30%) compared to the HR
group (21%) and the LR group (15%) at p < 0.001. Among
HR55 patients, 68% of the hospitalizations were CV-related.
HR55 patients experienced an average of 34 ambulatory visits
in the 24-month Follow-up period, signiﬁcantly greater than HR
patients (28 visits, p < 0.001) and LR patients (24 visits, p <
